Alpha-foetoprotein: further evidence to add a biological marker to refine Milan criteria
Liver Int
.
2016 Nov;36(11):1580-1581.
doi: 10.1111/liv.13184.
Authors
Christian Toso
1
2
3
,
Axel Andres
1
2
3
,
Norman Kneteman
4
,
Roberto Hernandez-Alejandro
5
,
Pietro Majno
1
2
3
Affiliations
1
Division of Abdominal and Transplant Surgery, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland.
2
Hepatobiliary and Pancreas Center, Geneva University Hospitals, Geneva, Switzerland.
3
Faculty of Medicine, University of Geneva, Geneva, Switzerland.
4
Division of Transplantation, Department of Surgery, University of Alberta, Edmonton, AB, Canada.
5
Multi-Organ Transplant Program, London Health Sciences Centre, Western University, Canada, London, ON, Canada.
PMID:
27744652
DOI:
10.1111/liv.13184
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biomarkers
Carcinoma, Hepatocellular
Humans
Liver Neoplasms*
Liver Transplantation
alpha-Fetoproteins*
Substances
Biomarkers
alpha-Fetoproteins